H
AMPE

HoyleCohen’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

HoyleCohen’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-33
Closed -$2K – 266
2022
Q2 		$2K Hold
33
– – ﹤0.01% 260
2022
Q1 		$5K Hold
33
– – ﹤0.01% 274
2021
Q4 		$6K Hold
33
– – ﹤0.01% 277
2021
Q3 		$17K Hold
33
– – ﹤0.01% 267
2021
Q2 		$17 Hold
33
– – ﹤0.01% 267
2021
Q1 		$17K Buy
+33
New +$17K ﹤0.01% 267

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
SA
Shilanski & Associates Anchorage, Alaska $376M AUM 19.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

HoyleCohen's AMPE Position: Q3 2022 in Review

HoyleCohen sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2022, closing a stake of 33 shares — an estimated $2K sold.

HoyleCohen first reported a position in AMPE in Q1 2021 and held it in 6 quarters. The position peaked at $17K in Q3 2021. 95 funds tracked by Wall St. Rank hold AMPE as of Q3 2022.

  • HoyleCohen reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2022 after selling out during the quarter.
  • HoyleCohen sold 33 Ampio Pharmaceuticals Inc. shares in Q3 2022, an estimated $2K.
  • HoyleCohen first reported a position in Ampio Pharmaceuticals Inc. in Q1 2021 and held it in 6 quarters.
  • HoyleCohen's Ampio Pharmaceuticals Inc. position peaked at $17K in Q3 2021.
  • 95 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2022.

Based on HoyleCohen's 13F filing for Q3 2022, filed 2 Nov 2022.